Unaudited Condensed Consolidated Statements of Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net revenue		$ 27,667	$ 44,367
Cost of revenue		15,054	27,202
Gross profit		12,613	17,165
Operating expenses:
Research and product development		7,034	9,601
Selling, marketing, general and administrative		14,993	19,579
Restructuring and other charges		288	4,152
Amortization of intangible assets		1,190	1,271
Total operating expenses		23,505	34,603
Operating loss		(10,892)	(17,438)
Interest expense, net		(1,213)	(626)
Other income (expense), net		(324)	481
Loss from continuing operations before income taxes		(12,429)	(17,583)
Income tax provision		1,106	2,452
Net Loss from continuing operations		(13,535)	(20,035)
Loss from discontinued operations, net of income tax provision		(5,171)	(3,782)
Net loss		(18,706)	(23,817)
Foreign currency translation adjustments	[1]	(1,320)	(1,889)
Actuarial loss		(38)	(60)
Comprehensive loss		$ (20,064)	$ (25,766)
Income (Loss) from Continuing Operations, Per Basic Share		$ (0.36)	$ (0.65)
Income (Loss) from Continuing Operations, Per Diluted Share		(0.36)	(0.65)
Net loss per share from continuing operations
Basic (in dollars per share)		(0.36)	(0.65)
Diluted (in dollars per share)		(0.36)	(0.65)
Basic (in dollar per share)		(0.14)	(0.12)
Diluted (in dollar per share)		$ (0.14)	$ (0.12)
Weighted average shares outstanding
Basic (in shares)		37,399	31,045
Diluted (in shares)		37,399	31,045

[1] Includes net loss of $0.3 million on intra-entity foreign currency transactions that are of a long-term investment nature for three months ended March 31, 2024. Includes net gain of $0.2 million on intra-entity foreign currency transactions that are of a long-term investment nature for three months ended March 31, 2023.